首页> 外国专利> MICROARRAY FOR ASSESSING NEUROBLASTOMA PROGNOSIS AND METHOD OF ASSESSING NEUROBLASTOMA PROGNOSIS

MICROARRAY FOR ASSESSING NEUROBLASTOMA PROGNOSIS AND METHOD OF ASSESSING NEUROBLASTOMA PROGNOSIS

机译:评估神经母细胞瘤预后的微阵列和评估神经母细胞瘤预后的方法

摘要

A microarray for predicting the prognosis of neuroblastoma, wherein the microarray has 25 to 45 probes related to good prognosis, which are hybridized to a gene transcript whose expression is increased in a good prognosis patient with neuroblastoma and are selected from 96 polynucleotides consisting of the nucleotide sequences of Seq. ID No. 1 to 96 or their partial continuous sequences or their complementary strands, and 25 to 45 probes related to poor prognosis, which are hybridized to a gene transcript whose expression is increased in a poor prognosis patient with neuroblastoma and are selected from 104 polynucleotides consisting of the nucleotide sequences of Seq. ID No. 97 to 200 or their partial continuous sequences or their complementary strands.
机译:一种用于预测神经母细胞瘤预后的微阵列,其中所述微阵列具有与良好预后相关的25至45个探针,其与在具有良好预后的神经母细胞瘤患者中表达增加的基因转录物杂交,并选自由96个核苷酸组成的多核苷酸Seq。的序列将ID No.1到96或它们的部分连续序列或其互补链以及25到45个与预后不良相关的探针杂交,将其与在神经母细胞瘤的预后不良患者中表达增加的基因转录物杂交,并选自104个多核苷酸由Seq。的核苷酸序列组成。 ID号97至200或其部分连续序列或其互补链。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号